Paolo Aretini
机构: Bioinformatic Analyst, Fondazione Pisana per la Scienza ONLUS, Pisa
主页: fpscience.it
每年引用次数
引用次数
引用: 3,886
H-指数: 29
I10-指数 : 64
出版物: 154
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations
F Marroni , P Aretini , Emma D’Andrea , MA Caligo
Journal of Medical Genetics 41 ( 4) 278 -285
51
2004
Evaluation of widely used BRCA1/2-mutation-predicting models
F Marroni , P Aretini , E D'Andrea , MA Caligo
JOURNAL OF MEDICAL GENETICS 41 278 -285
1
2004
Unbiased estimation of breast and ovarian cancer penetrances in BRCA1/2 mutation carriers using genetic-test results.
F Marroni , P Aretini , Bailey Wilson JE , G Bevilacquaa
AMERICAN JOURNAL OF HUMAN GENETICS 73 ( 5) 234 -234
1
2003
Performance of different models predicting BFICA-mutation carrier status in 570 Italian families.
F Marroni , P Aretini , Bailey Wilson JE , G Parmigiani
AMERICAN JOURNAL OF HUMAN GENETICS 71 ( 4) 348 -348
2002
Clinical presentation in BRCA1/2 mutation carriers: a single-institution experience.
I Ferrarini , A Fontana , P Aretini , E Bona
TUMORI S118 -S119
2012
POS0303 CROSSING THE BARRIERS: DYSBIOSIS AND SUBCLINICAL UTERINE INFLAMMATION IN THE PATHOGENESIS OF AxSpA IN FEMALES. ANOTHER BREAK IN THE WALL?
D Mauro , M Vecellio , E Schmid , AS Bergot
Annals of the Rheumatic Diseases 83 ( Suppl 1) 269 -269
2024
Neuronal injury induces connective tissue growth factor expression to support peripheral neuroregeneration
S Negro , M Stazi , G D'Este , P Aretini
GLIA 67 E671 -E672
2019
Platelet lncRNA and mRNA: unravelling the role of epigenetic modulation in acute coronary syndrome
MC Grimaldi , I Fabiani , P Aretini , CM Mazzanti
EUROPEAN HEART JOURNAL 40 3290 -3290
2019
Learning and actioning general principles of cancer cell drug sensitivity
F Carli , P Di Chiaro , M Morelli , C Arora
2024
CXCL12a/SDF-1 from perisynaptic Schwann cells promotes regeneration after motor axon terminal injury
S Negro , F Lessi , E Duregotti , P Aretini
GLIA 65 E528 -E528
2017
P10. 10. B BIRC3 AS A PREDICTOR OF OUTCOME AND A NEW THERAPEUTIC TARGET IN TMZ RESISTANT GLIOBLASTOMA TUMORS
M Morelli , S Franceschi , F Lessi , P Aretini
Neuro-Oncology 25 ( Supplement_2) ii64 -ii64
2023
GERMLINE INVESTIGATION IN DNA REPAIR GENES OF MALE BREAST CANCER BY NEXT-GENERATION SEQUENCING
MA Caligo , R Scarpitta , G Gambino , P Aretini
EUROPEAN JOURNAL OF HUMAN GENETICS 27 442 -443
2019
Utility of a gene expression panel as a screening tool for human mammary tumour virus infection in breast cancer
C Scatena , P Civita , F Lessi , P Aretini
VIRCHOWS ARCHIV 475 S16 -S16
2019
The metastatic potential of grade 1 breast carcinoma of no special type: A deep insight into putative molecular mechanisms
C Scatena , C Scopelliti , P Aretini , F Lessi
VIRCHOWS ARCHIV 471 S53 -S53
2017
P14. 04. b circulating tumor cells as a non-invasive glioblastoma diagnostic and prognostic tool
F Lessi , M Morelli , S Franceschi , P Aretini
Neuro-Oncology 25 ( Supplement_2) ii106 -ii106
1
2023
Correction to: Hospitalization length, surgical duration, and blood lost among the approaches for total hip arthroplasty: a Bayesian network meta‑analysis
F Migliorini , A Trivellas , J Eschweiler , Y El Mansy
Musculoskeletal surgery 105 207 -207
1
2021
Circulating Tumor Cells as a Non-invasive Glioblastoma Diagnostic and Prognostic Tool
F Lessi , M Morelli , S Franceschi , P Aretini
The Journal of Liquid Biopsy 1
2023
Detection of Circulating Tumor Cells in Peripheral Blood of Pediatric Osteosarcoma Patients
M Morelli , F Lessi , R Gaeta , A Di Gangi
The Journal of Liquid Biopsy 1
2023
ISOLATION AND CHARACTERIZATION OF CIRCULATING TUMOR CELLS IN A GLIOBLASTOMA CASE WITH RECURRENCE AT DISTANCE AND CORRELATION WITH TUMOR MUTATIONAL STATUS
F Lessi , M Morelli , P Aretini , M Menicagli
NEURO-ONCOLOGY 24
2022
METABOLIC-IMAGING OF HUMAN GLIOBLASTOMA EXPLANTS: A NEW PRECISION-MEDICINE MODEL TO PREDICT TREATMENT RESPONSE EARLY
C Mazzanti , M Morelli , F Lessi , A Anna Luisa
NEURO-ONCOLOGY 24
2022